Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation

被引:2
|
作者
Cox, Ben [1 ]
Carrique, Lauren [1 ]
Di Maira, Tommaso [1 ,2 ,3 ,4 ]
Sales, Isabel [1 ]
Don, Caitlin [5 ]
Gomez-Aldana, A. [1 ]
Koshy, Dilip [5 ]
Abbey, Susan [5 ]
Lilly, Les [1 ]
Tsien, Cynthia [1 ]
Bhat, Mamatha [1 ,6 ]
Jaeckel, Elmar [1 ]
Lynch, Marie-Josee [1 ,5 ]
Selzner, Nazia [1 ,7 ]
机构
[1] Univ Toronto, Univ Hlth Network, Ajmera Transplant Ctr, Toronto, ON, Canada
[2] Hosp Univ La Fe, Liver Transplantat & Hepatol Unit, Valencia, Spain
[3] Inst Salud Carlos III, CIBERehd, Madrid, Spain
[4] IIS La Fe, Valencia, Spain
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Toronto Gen Hosp, Ajmera Transplant Ctr, Toronto, ON M5M2P3, Canada
关键词
D O I
10.1097/LVT.0000000000000274
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Since 2018, our program has utilized specific psychosocial criteria and a multidisciplinary approach to assess patients for liver transplant due to alcohol-associated liver disease (ALD), rather than the 6-month abstinence rule alone. If declined based on these criteria, specific recommendations are provided to patients and their providers regarding goals for re-referral to increase the potential for future transplant candidacy. Recommendations include engagement in treatment for alcohol use disorder, serial negative biomarker testing, and maintenance of abstinence from alcohol. In our current study, we evaluate the outcomes of patients with ALD, who were initially declined upon assessment and re-referred to our program. This is a retrospective cohort study that includes 98 patients with ALD, who were previously declined for liver transplantation and were subsequently re-referred for liver transplant assessment between May 1, 2018, and December 31, 2021. We assess the outcomes of patients who were re-referred including acceptance for transplantation following a second assessment. Of the 98 patients who were re-referred, 46 (46.9%) fulfilled the recommendations made and proceeded to further medical evaluation. Nine were eventually transplanted; others are listed and are waiting for transplant. The presence of a partner was independently associated with a higher rate of acceptance (OR 0.16, 95% CI: 0.03-0.97, p = 0.05). Most of the patients who did not proceed further (n = 52) were declined again due to ALD contraindications (n = 33, 63.4%), including ongoing drinking and lack of engagement in recommended addiction treatment. Others had medical contraindications (11.2%), clinically improved (6.1%), had adherence issues (5.1%), or lack of adequate support (2%). Patients with ALD previously declined for a liver transplant can be re-referred and successfully accepted for transplantation by fulfilling the recommendations made by the multidisciplinary team. Important factors including ongoing abstinence, engagement in addiction treatment, and social support are key for successful acceptance.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 50 条
  • [1] Outcomes of re-referrals for patients with alcohol-related liver disease who were previously declined for liver transplantation
    Cox, B.
    Carrique, L.
    Di Maira, T.
    Sales, I.
    Don, C.
    Gomez-Aldana, A.
    Koshy, D.
    Abbey, S.
    Lilly, L.
    Tsien, C.
    Bhat, M.
    Jaeckel, E.
    Lynch, J.
    Selzner, N.
    TRANSPLANTATION, 2023, 107 (09) : 198 - 198
  • [2] Indications for and outcomes of liver transplantation in patients with alcohol-associated liver disease
    Phillips, Paulina K.
    Caldis, Matthew W.
    Hristov, Alexander D.
    Lee, Alexander S.
    Lucey, Michael R. .
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (02) : 126 - 137
  • [3] Complications in Patients with Alcohol-Associated Liver Disease Who Undergo Liver Transplantation
    Gaglio, Paul J., Jr.
    Gaglio, Paul J., Sr.
    CLINICS IN LIVER DISEASE, 2012, 16 (04) : 865 - +
  • [4] Liver transplant evaluation redux: Hope for reconsidering previously declined candidates with alcohol-associated liver disease
    Winder, Gerald Scott
    Mellinger, Jessica L.
    LIVER TRANSPLANTATION, 2024, 30 (03) : 237 - 239
  • [5] Liver transplantation for Alcohol-associated liver disease
    Simonetto, Douglas A.
    Winder, G. Scott
    Connor, Ashton A.
    Terrault, Norah A.
    HEPATOLOGY, 2024, 80 (06) : 1441 - 1461
  • [6] Epidemiological trends in presentation and outcomes, including liver transplantation in patients with alcohol-associated liver disease
    Singal, A. K.
    Kuo, Y. F.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 48 - 48
  • [7] The landscape of liver transplantation for patients with alcohol-associated liver disease in the United States
    Vock, David M.
    Humphreville, Vanessa
    Ramanathan, Karthik V.
    Adams, Andrew B.
    Lim, Nicholas
    Nguyen, Vinh H.
    Wothe, Jillian K.
    Chinnakotla, Srinath
    LIVER TRANSPLANTATION, 2025, 31 (01) : 32 - 44
  • [8] Outcomes from early liver transplantation for alcohol-associated liver disease at a single center
    Meinders, A.
    Connor, A. A.
    Patel, K.
    Ontiveros, J.
    Nottage, D. L.
    Brombosz, E. W.
    Moore, L. W.
    Simon, C. J.
    Cheah, Y. L.
    Hobeika, M.
    Mobley, C. M.
    Saharia, A.
    Basra, T.
    Kodali, S.
    Victor, D. W., III
    Gaber, A. O.
    Ghobrial, R. M.
    LIVER TRANSPLANTATION, 2024, 30 : 52 - 52
  • [9] The Ongoing Evolution of Liver Transplantation in Alcohol-Associated Liver Disease
    Rice, John P.
    LIVER TRANSPLANTATION, 2021, 27 (01) : 12 - 13
  • [10] Changing Times in Liver Transplantation for Alcohol-Associated Liver Disease
    Mitchell, Mack C.
    Maddrey, Willis C.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 348 - 350